Literature DB >> 15133614

[Modern differential therapy with diuretics].

D Fliser1, H Haller.   

Abstract

Diuretics block different electrolyte transporters in renal tubular cells. Their predominant action is inhibition of renal sodium chloride reabsorption, however, and achievement of a negative body sodium balance is the principal goal of diuretic therapy in patients with hypertension and edema. Several classes of diuretics can be distinguished with respect to the sites of sodium reabsorption along the nephron, but loop diuretics and distal-tubular diuretics (incl. thiazides) are the most widely used. The latter have a less potent natriuretic effect than loop diuretics, but their long duration of action predispose them for treatment of patients with uncomplicated hypertension. In conditions of gross edema, e.g. heart and/or renal failure, distal-tubular diuretics lose their efficacy and must be replaced by or combined with loop diuretics ("sequential nephron blockade"). Aldosterone antagonists are unique among diuretics because they improve survival in patients with heart failure independently of their effect on sodium metabolism.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15133614     DOI: 10.1007/s00108-003-1118-y

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  24 in total

1.  1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. Guidelines Subcommittee.

Authors: 
Journal:  J Hypertens       Date:  1999-02       Impact factor: 4.844

2.  Guidelines for the diagnosis and treatment of chronic heart failure.

Authors:  W J Remme; K Swedberg
Journal:  Eur Heart J       Date:  2001-09       Impact factor: 29.983

3.  [Guidelines for the treatment of chronic heart failure. Issued by the Executive Committee of the German Society of Cardiology--Heart and Circulation Research, compiled on behalf of the Commission of Clinical Cardiology in cooperation with Pharmaceutic Commission of the German Physicians' Association].

Authors:  U C Hoppe; E Erdmann
Journal:  Z Kardiol       Date:  2001-03

4.  Mechanism of impaired natriuretic response to furosemide during prolonged therapy.

Authors:  N R Loon; C S Wilcox; R J Unwin
Journal:  Kidney Int       Date:  1989-10       Impact factor: 10.612

5.  Diuretic effect of frusemide in patients with nephrotic syndrome: is it potentiated by intravenous albumin?

Authors:  F Akcicek; T Yalniz; A Basci; E Ok; E J Mees
Journal:  BMJ       Date:  1995-01-21

Review 6.  The physiologic basis of diuretic synergism: its role in treating diuretic resistance.

Authors:  D H Ellison
Journal:  Ann Intern Med       Date:  1991-05-15       Impact factor: 25.391

7.  Withdrawal of long-term diuretic medication in elderly patients: a double blind randomised trial.

Authors:  E P Walma; A W Hoes; C van Dooren; A Prins; E van der Does
Journal:  BMJ       Date:  1997-08-23

8.  Role of duration of diuretic effect in preventing sodium retention.

Authors:  J A Ferguson; K J Sundblad; P K Becker; J C Gorski; D W Rudy; D C Brater
Journal:  Clin Pharmacol Ther       Date:  1997-08       Impact factor: 6.875

9.  Coadministration of albumin and furosemide in patients with the nephrotic syndrome.

Authors:  D Fliser; I Zurbrüggen; E Mutschler; I Bischoff; J Nussberger; E Franek; E Ritz
Journal:  Kidney Int       Date:  1999-02       Impact factor: 10.612

10.  Diuretic therapy for hypertension and the risk of primary cardiac arrest.

Authors:  D S Siscovick; T E Raghunathan; B M Psaty; T D Koepsell; K G Wicklund; X Lin; L Cobb; P M Rautaharju; M K Copass; E H Wagner
Journal:  N Engl J Med       Date:  1994-06-30       Impact factor: 91.245

View more
  1 in total

Review 1.  [Drug-related disorders of water and electrolyte metabolism].

Authors:  U Dendorfer; J Mann
Journal:  Internist (Berl)       Date:  2006-11       Impact factor: 0.743

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.